These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 26626178)

  • 41. A massive suspension culture system with metabolic purification for human pluripotent stem cell-derived cardiomyocytes.
    Hemmi N; Tohyama S; Nakajima K; Kanazawa H; Suzuki T; Hattori F; Seki T; Kishino Y; Hirano A; Okada M; Tabei R; Ohno R; Fujita C; Haruna T; Yuasa S; Sano M; Fujita J; Fukuda K
    Stem Cells Transl Med; 2014 Dec; 3(12):1473-83. PubMed ID: 25355733
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Generation of cardiac spheres from primate pluripotent stem cells in a small molecule-based 3D system.
    Jiang B; Xiang Z; Ai Z; Wang H; Li Y; Ji W; Li T
    Biomaterials; 2015 Oct; 65():103-14. PubMed ID: 26148474
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Maturation of Human Stem Cell-derived Cardiomyocytes in Biowires Using Electrical Stimulation.
    Sun X; Nunes SS
    J Vis Exp; 2017 May; (123):. PubMed ID: 28518082
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Characterization of the mechanodynamic response of cardiomyocytes with atomic force microscopy.
    Chang WT; Yu D; Lai YC; Lin KY; Liau I
    Anal Chem; 2013 Feb; 85(3):1395-400. PubMed ID: 23265281
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Bioengineering an electro-mechanically functional miniature ventricular heart chamber from human pluripotent stem cells.
    Li RA; Keung W; Cashman TJ; Backeris PC; Johnson BV; Bardot ES; Wong AOT; Chan PKW; Chan CWY; Costa KD
    Biomaterials; 2018 May; 163():116-127. PubMed ID: 29459321
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A Simple Protocol for the Generation of Cardiomyocytes from Human Pluripotent Stem Cells.
    Sequiera GL; Mehta A; Shim W
    Methods Mol Biol; 2016; 1307():379-83. PubMed ID: 24297314
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Combinatorial polymer matrices enhance in vitro maturation of human induced pluripotent stem cell-derived cardiomyocytes.
    Chun YW; Balikov DA; Feaster TK; Williams CH; Sheng CC; Lee JB; Boire TC; Neely MD; Bellan LM; Ess KC; Bowman AB; Sung HJ; Hong CC
    Biomaterials; 2015 Oct; 67():52-64. PubMed ID: 26204225
    [TBL] [Abstract][Full Text] [Related]  

  • 48. High Throughput Measurement of Ca++ Dynamics in Human Stem Cell-Derived Cardiomyocytes by Kinetic Image Cytometery: A Cardiac Risk Assessment Characterization Using a Large Panel of Cardioactive and Inactive Compounds.
    Lu HR; Whittaker R; Price JH; Vega R; Pfeiffer ER; Cerignoli F; Towart R; Gallacher DJ
    Toxicol Sci; 2015 Dec; 148(2):503-16. PubMed ID: 26358003
    [TBL] [Abstract][Full Text] [Related]  

  • 49. An Optical-Flow-Based Method to Quantify Dynamic Behavior of Human Pluripotent Stem Cell-Derived Cardiomyocytes in Disease Modeling Platforms.
    Izadifar M; Berecz T; Apáti Á; Nagy A
    Methods Mol Biol; 2022; 2454():213-230. PubMed ID: 33982275
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Extracellular Matrix-Mediated Maturation of Human Pluripotent Stem Cell-Derived Cardiac Monolayer Structure and Electrophysiological Function.
    Herron TJ; Rocha AM; Campbell KF; Ponce-Balbuena D; Willis BC; Guerrero-Serna G; Liu Q; Klos M; Musa H; Zarzoso M; Bizy A; Furness J; Anumonwo J; Mironov S; Jalife J
    Circ Arrhythm Electrophysiol; 2016 Apr; 9(4):e003638. PubMed ID: 27069088
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Evaluation of Changes in Morphology and Function of Human Induced Pluripotent Stem Cell Derived Cardiomyocytes (HiPSC-CMs) Cultured on an Aligned-Nanofiber Cardiac Patch.
    Khan M; Xu Y; Hua S; Johnson J; Belevych A; Janssen PM; Gyorke S; Guan J; Angelos MG
    PLoS One; 2015; 10(5):e0126338. PubMed ID: 25993466
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Bridging Functional and Structural Cardiotoxicity Assays Using Human Embryonic Stem Cell-Derived Cardiomyocytes for a More Comprehensive Risk Assessment.
    Clements M; Millar V; Williams AS; Kalinka S
    Toxicol Sci; 2015 Nov; 148(1):241-60. PubMed ID: 26259608
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Human pluripotent stem cell-derived cardiomyocyte based models for cardiotoxicity and drug discovery.
    Zhao Y; Korolj A; Feric N; Radisic M
    Expert Opin Drug Saf; 2016 Nov; 15(11):1455-1458. PubMed ID: 27560951
    [No Abstract]   [Full Text] [Related]  

  • 54. Mechanistic basis of excitation-contraction coupling in human pluripotent stem cell-derived ventricular cardiomyocytes revealed by Ca2+ spark characteristics: direct evidence of functional Ca2+-induced Ca2+ release.
    Li S; Cheng H; Tomaselli GF; Li RA
    Heart Rhythm; 2014 Jan; 11(1):133-40. PubMed ID: 24096168
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effects of substrate mechanics on contractility of cardiomyocytes generated from human pluripotent stem cells.
    Hazeltine LB; Simmons CS; Salick MR; Lian X; Badur MG; Han W; Delgado SM; Wakatsuki T; Crone WC; Pruitt BL; Palecek SP
    Int J Cell Biol; 2012; 2012():508294. PubMed ID: 22649451
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Differentiation and enrichment of cardiomyocytes from human pluripotent stem cells.
    Xu C
    J Mol Cell Cardiol; 2012 Jun; 52(6):1203-12. PubMed ID: 22484618
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Substrate and mechanotransduction influence SERCA2a localization in human pluripotent stem cell-derived cardiomyocytes affecting functional performance.
    Martewicz S; Serena E; Zatti S; Keller G; Elvassore N
    Stem Cell Res; 2017 Dec; 25():107-114. PubMed ID: 29125993
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Concise Review: Measuring Physiological Responses of Human Pluripotent Stem Cell Derived Cardiomyocytes to Drugs and Disease.
    van Meer BJ; Tertoolen LG; Mummery CL
    Stem Cells; 2016 Aug; 34(8):2008-15. PubMed ID: 27250776
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Determination of appropriate stage of human-induced pluripotent stem cell-derived cardiomyocytes for drug screening and pharmacological evaluation in vitro.
    Shinozawa T; Imahashi K; Sawada H; Furukawa H; Takami K
    J Biomol Screen; 2012 Oct; 17(9):1192-203. PubMed ID: 22706346
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Functional Characterization and Comparison of Intercellular Communication in Stem Cell-Derived Cardiomyocytes.
    Marcu IC; Illaste A; Heuking P; Jaconi ME; Ullrich ND
    Stem Cells; 2015 Jul; 33(7):2208-18. PubMed ID: 25968594
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.